Switching Therapies in CML Treatment
Chapter 4In this video Hagop M. Kantarjian, MD, a professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, discusses the decisions related to switching therapy for patients with chronic myeloid leukemia.
Progress in the Landscape of CML Treatment
In this video Hagop M. Kantarjian, MD, a professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, reviews the progress in treatment strategies for patients with chronic myeloid leukemia over the last 16 years.
Sequencing Treatment for Patients with CML
In this video Hagop M. Kantarjian, MD, a professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, reviews the available tyrosine kinase inhibitors for the treatment of CML and his strategy for sequencing treatment in patients with chronic myeloid leukemia.
Monitoring Treatment Response in Patients With CML
In this video Hagop M. Kantarjian, MD, a professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, highlights the importance of monitoring patients with chronic myeloid leukemia and gives specific guidance on best practices.
Known Factors in TKI Resistance
In this video Hagop M. Kantarjian, MD, a professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, reviews the facts that can cause tyrosine kinase resistance and how they should be addressed in the clinical setting.
Allogeneic Stem Cell Transplant in CML
In this video Hagop M. Kantarjian, MD, a professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, outlines the appropriate scenarios for the consideration of allogeneic stem cell transplant in patients with chronic myeloid leukemia.
The Future of CML Treatment
In this video Hagop M. Kantarjian, MD, a professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, discusses what he feels are the most important considerations in the future of CML treatment and research.
